MicroRNA ‐21a‐5p Promotes Cerebral Angiogenesis in Transient Ischemic Attack by Targeting RBMS3 and Subsequently Modulating the TGFBR1 / SMAD2 /3 Pathway
CNS Neuroscience & Therapeutics · 2025
DOI: 10.1111/cns.70573 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, 2025. Verfasst von Jiahui Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Hauptthemen laut MEDLINE: MicroRNAs, Receptor, Transforming Growth Factor-beta Type I, Ischemic Attack, Transient, Smad2 Protein. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Nature Science Foundation of China, Major Program (JD) of Hubei Province, Key Research and Development Program of Wuhan.
Abstract (Originalsprache)
Aims
Transient ischemic attack (TIA) serves as a crucial precursor to a potential stroke. Angiogenesis is essential for the renovation of the damaged brain after TIA. This study aimed to elucidate the role of miRNA‐21a‐5p in angiogenesis following TIA and unravel the underlying mechanisms.
Methods
In vivo and in vitro TIA models were established using the modified suture middle cerebral artery occlusion and oxygen–glucose deprivation/reoxygenation methods. Differentially expressed miRNAs in the TIA group versus the control group were identified using small RNA sequencing. The putative target genes of miRNA‐21a‐5p were predicted via bioinformatics analysis and validated using a dual luciferase reporter gene assay. TIA models were then treated with miRNA‐21a‐5p antagomir/agomir or/and an adeno‐associated virus interfering with the target gene to assess the effects of miRNA‐21a‐5p and the identified target gene on angiogenesis after TIA.
Results
MiRNA‐21a‐5p was the miRNA with the most significant changes after TIA. RBMS3 was identified as a target gene for miRNA‐21a‐5p. Downregulation of miRNA‐21a‐5p expression reduced angiogenesis in animal and cellular models of TIA, and miRNA‐21a‐5p upregulation had a completely opposite effect. RBMS3 suppression reversed miRNA‐21a‐5p knockdown‐mediated inhibition of angiogenesis in TIA models. Moreover, the TGFBR1/SMAD2/3 pathway was found to be downstream for miRNA ‐ 21a‐5p/RBMS3.
Conclusion
MiRNA‐21a‐5p conferred neuroprotective effects against TIA by enhancing angiogenesis through the RBMS3/TGFBR1/SMAD2/3 pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Department of Neurology, the Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, China.
ORCID-Profile: Zhouping Tang
Förderung
- National Nature Science Foundation of China
- Major Program (JD) of Hubei Province
- Key Research and Development Program of Wuhan
- Interdisciplinary Research Program of Huazhong University of Science and Technology
- Research Fund of Tongji Hospital
- National Natural Science Foundation of China
- Justis- og beredskapsdepartementet
Zitieren
APA
Wang, J., Li, Y., Wang, J., Chen, S., Nie, L., Wu, X., Li, J., Zhang, P., & Tang, Z. (2025). MicroRNA ‐21a‐5p Promotes Cerebral Angiogenesis in Transient Ischemic Attack by Targeting RBMS3 and Subsequently Modulating the TGFBR1 / SMAD2 /3 Pathway. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.70573
Vancouver
Wang J, Li Y, Wang J, Chen S, Nie L, Wu X, et al. MicroRNA ‐21a‐5p Promotes Cerebral Angiogenesis in Transient Ischemic Attack by Targeting RBMS3 and Subsequently Modulating the TGFBR1 / SMAD2 /3 Pathway. CNS Neuroscience & Therapeutics. 2025. doi:10.1111/cns.70573
BibTeX
@article{Wang2025,
author = {Wang, Jiahui and Li, Yanyan and Wang, Jingyi and Chen, Shiling and Nie, Luwei and Wu, Xuan and Li, Jiarui and Zhang, Ping and Tang, Zhouping},
title = {MicroRNA ‐21a‐5p Promotes Cerebral Angiogenesis in Transient Ischemic Attack by Targeting RBMS3 and Subsequently Modulating the TGFBR1 / SMAD2 /3 Pathway},
journal = {CNS Neuroscience & Therapeutics},
year = {2025},
doi = {10.1111/cns.70573}
}
EUVIMED